{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:30:35Z","timestamp":1770841835071,"version":"3.50.1"},"reference-count":68,"publisher":"Informa UK Limited","issue":"6","funder":[{"DOI":"10.13039\/100007787","name":"National Research Centre","doi-asserted-by":"publisher","award":["12020206"],"award-info":[{"award-number":["12020206"]}],"id":[{"id":"10.13039\/100007787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Delivery"],"published-print":{"date-parts":[[2024,6,2]]},"DOI":"10.4155\/tde-2023-0121","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T12:37:16Z","timestamp":1715949436000},"page":"413-426","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Alleviation of doxorubicin adverse effects via loading into various drug-delivery systems: a comparative study"],"prefix":"10.1080","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8113-8834","authenticated-orcid":false,"given":"Rehab M","family":"Abdel-Megeed","sequence":"first","affiliation":[{"name":"Therapeutic Chemistry Department, Pharmaceutical &amp; Drug Industries Research Institute, National Research Center, El Buhouth St, Dokki, Cairo, 12622, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0818-5738","authenticated-orcid":false,"given":"Hassan Z","family":"Ghanem","sequence":"additional","affiliation":[{"name":"Therapeutic Chemistry Department, Pharmaceutical &amp; Drug Industries Research Institute, National Research Center, El Buhouth St, Dokki, Cairo, 12622, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai O","family":"Kadry","sequence":"additional","affiliation":[{"name":"Therapeutic Chemistry Department, Pharmaceutical &amp; Drug Industries Research Institute, National Research Center, El Buhouth St, Dokki, Cairo, 12622, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,4,19]]},"reference":[{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2019.188314"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89931-9"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.2217\/hep.15.41"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-022-00888-w"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.12.276"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.03.053"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2019.102110"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2016.10.003"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-023-06894-3"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh097"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.8331"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2009.05.015"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1166\/jnn.2011.3114"},{"key":"e_1_3_8_16_1","first-page":"2321","article-title":"Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles","volume":"18","author":"Chen Y","year":"2011","unstructured":"Chen Y, Wan Y, Wang Y et al. Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles. Inter. J. Nanomed. 2011;18: 2321\u20132326.","journal-title":"Inter. J. Nanomed."},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.1139\/bcb-2020-0087"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/01480545.2019.1585868"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.3168\/jds.2010-3629"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0988"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.3168\/jds.2009-2926"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2006.07.014"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fbinf.2021.706835"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4379-5"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.510"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-48"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061522"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.13250"},{"key":"e_1_3_8_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14040855"},{"key":"e_1_3_8_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-013-0907-x"},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-016-0184-y"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-018-3404-y"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1691"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2020.10.018"},{"key":"e_1_3_8_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/28.1.56"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.13398"},{"key":"e_1_3_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2018.01.007"},{"key":"e_1_3_8_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/jsfa.2740011103"},{"key":"e_1_3_8_39_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja01381a006"},{"key":"e_1_3_8_40_1","first-page":"164","article-title":"Fucosidosis: diagnosis by serum assay of \u03b1-l-fucosidase","volume":"79","author":"Zielke K","year":"1972","unstructured":"Zielke K, Okada S, O'Brien JS. Fucosidosis: diagnosis by serum assay of \u03b1-l-fucosidase. J. Lab. Clin. Med. 1972;79:164\u2013169.","journal-title":"J. Lab. Clin. Med."},{"key":"e_1_3_8_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2008.08.016"},{"key":"e_1_3_8_42_1","first-page":"1137","article-title":"Autophagy regulation in the context of arsenic trioxide-induced cardiotoxicity via flaxseed oil: myosin heavy chain, BNP and SIRT1 genetic association","volume":"65","author":"Abdel-Megeed RM","year":"2022","unstructured":"Abdel-Megeed RM, Kadry MO. Autophagy regulation in the context of arsenic trioxide-induced cardiotoxicity via flaxseed oil: myosin heavy chain, BNP and SIRT1 genetic association. Egyptian J. Chem. 2022;65:1137\u20131146.","journal-title":"Egyptian J. Chem."},{"key":"e_1_3_8_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-020-00535-y"},{"key":"e_1_3_8_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43141-022-00430-4"},{"key":"e_1_3_8_45_1","doi-asserted-by":"publisher","DOI":"10.14218\/GE.2023.00069"},{"key":"e_1_3_8_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24356"},{"key":"e_1_3_8_47_1","doi-asserted-by":"publisher","DOI":"10.1590\/1519-6984.186565"},{"key":"e_1_3_8_48_1","first-page":"127","article-title":"Liposomes as drug carriers in cancer therapy","volume":"68","author":"Weinstein JN","year":"1984","unstructured":"Weinstein JN. Liposomes as drug carriers in cancer therapy. Cancer Treat Rep. 1984;68:127\u2013135.","journal-title":"Cancer Treat Rep."},{"key":"e_1_3_8_49_1","first-page":"3765","article-title":"Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue","volume":"53","author":"Wu NZ","year":"1993","unstructured":"Wu NZ, Da D, Rudoll TL et al. Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue. Cancer Res. 1993;53:3765\u20133770.","journal-title":"Cancer Res."},{"key":"e_1_3_8_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9098(199607)62:3<186::AID-JSO8>3.0.CO;2-3"},{"key":"e_1_3_8_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602394"},{"key":"e_1_3_8_52_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-012-0819-3","article-title":"Size-mediated cytotoxicity of nanocrystalline titanium dioxide, pure and zinc-doped hydroxyapatite nanoparticles in human hepatoma cells","volume":"14","author":"Devanand Venkatasubbu G","year":"2012","unstructured":"Devanand Venkatasubbu G, Ramasamy S, Avadhani G et al. Size-mediated cytotoxicity of nanocrystalline titanium dioxide, pure and zinc-doped hydroxyapatite nanoparticles in human hepatoma cells. J. Nanopart. Res. 2012;14:1\u201318.","journal-title":"J. Nanopart. Res."},{"key":"e_1_3_8_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-015-4838-8"},{"key":"e_1_3_8_54_1","first-page":"1","article-title":"Novel greenly synthesized titanium dioxide nanoparticles compared to liposomes in drug delivery: in vivo investigation on Ehrlich solid tumor model","volume":"7","author":"Fadeel DAA","year":"2021","unstructured":"Fadeel DAA, Hanafy MS, Kelany NA et al. Novel greenly synthesized titanium dioxide nanoparticles compared to liposomes in drug delivery: in vivo investigation on Ehrlich solid tumor model. Heliyon 2021;7:1\u20137.","journal-title":"Heliyon"},{"key":"e_1_3_8_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/tox.22773"},{"key":"e_1_3_8_56_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu14010042"},{"key":"e_1_3_8_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25578"},{"key":"e_1_3_8_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1989.84"},{"key":"e_1_3_8_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajg.2012.03.006"},{"key":"e_1_3_8_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21190"},{"key":"e_1_3_8_61_1","doi-asserted-by":"publisher","DOI":"10.4137\/CMT.S10409"},{"key":"e_1_3_8_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-023-06894-3"},{"key":"e_1_3_8_63_1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v2.i1.16"},{"key":"e_1_3_8_64_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105381"},{"key":"e_1_3_8_65_1","doi-asserted-by":"publisher","DOI":"10.3390\/ma14123155"},{"key":"e_1_3_8_66_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13122181"},{"key":"e_1_3_8_67_1","first-page":"5123","article-title":"Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma","volume":"12","author":"Wei M","year":"2015","unstructured":"Wei M, Guo X, Tu L, Zou Q et al. Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma. Int. J. Nanomed. 2015;12:5123\u20135137.","journal-title":"Int. J. Nanomed."},{"key":"e_1_3_8_68_1","first-page":"1299","article-title":"Peiminine serves as an adriamycin chemosensitizer in gastric cancer by modulating the EGFR\/FAK pathway","volume":"39","author":"Tang Q","year":"2018","unstructured":"Tang Q, Wang Y, Ma L et al. Peiminine serves as an adriamycin chemosensitizer in gastric cancer by modulating the EGFR\/FAK pathway. Oncol. Report. 2018;39:1299\u20131305.","journal-title":"Oncol. Report."},{"key":"e_1_3_8_69_1","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2017.1385859"},{"key":"e_1_3_8_70_1","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S304524"}],"container-title":["Therapeutic Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/tde-2023-0121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T23:24:14Z","timestamp":1727220254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/tde-2023-0121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,2]]}},"alternative-id":["10.4155\/tde-2023-0121"],"URL":"https:\/\/doi.org\/10.4155\/tde-2023-0121","relation":{},"ISSN":["2041-5990","2041-6008"],"issn-type":[{"value":"2041-5990","type":"print"},{"value":"2041-6008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itde20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itde20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-11-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}